CAS 648895-38-9

Bapineuzumab

CAS : 648895-38-9

Anti-β-amyloid protein (APP) monoclonal antibody.

Ref: 3D-CLA1652

Bapineuzumab

CAS : 648895-38-9

Bapineuzumab (AAB-001) is a humanised monoclonal antibody targeting amyloid-beta (Aβ), soluble and oligomeric forms of amyloid β, Alzheimer's disease (AD).

Degré de pureté : 95%

Couleur et forme : Liquid

Masse moléculaire : 145.86 kDa

Ref: TM-T76738